Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12203098
Cells having solid tumor targeting backbone and use thereof
granted -
US 12195724
Methods of producing T cell populations enriched for stable regulatory T-cells
granted -
US 12187780
Car t-cells comprising inactivated CBL and CBL-B genes
granted -
US 12188005
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted -
US 12187777
Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof
granted -
US 12180509
Methods for reprograming non-pluripotent cells into pluripotent stem cells
granted -
US 12173317
Use of histone modifiers to reprogram effector T cells
granted -
US 12171785
Pluripotent cells derived from bone marrow and methods for isolation
granted -
US 12171786
Use of mesenchymal stem cells for the treatment of inflammation
granted -
US 12171818
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted -
US 12173274
Enhanced immune effector cells and use thereof
granted -
US 12173324
Differentiation of pancreatic endocrine cells
granted -
US 12170134
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12163153
Methods of manufacturing allogeneic CAR T cells
granted -
US 12161674
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
granted -
US 12159700
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12157778
Peptides for activation of cell signaling in osteoprogenitor cells
granted -
US 12139522
T-cells comprising two different chimeric antigen receptors and uses thereof
granted -
US 12109239
Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
granted -
US 12109236
Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function
granted -
US 12104172
Processes for generating TIL products enriched for tumor antigen-specific t-cells
granted -
US 12097223
Mesenchymal stromal cells and uses related thereto
granted -
US 12098182
Polypeptides, cells, and methods involving engineered CD16
granted -
US 12083191
Composition and methods for imaging cells
granted